<DOC>
	<DOCNO>NCT00462566</DOCNO>
	<brief_summary>The objective determine motor cortex stimulation work follow condition : 1 . Deafferentation facial pain , 2 . Upper extremity complex regional pain syndrome ( CRPS ) 3 . Brachial plexus avulsion phantom limb pain . Each group 6 patient ( total 18 ) study independently patient implant motor cortex stimulation system . They randomise either regular low stimulation set two arm study . Each arm last 3 month .</brief_summary>
	<brief_title>The Efficacy Motor Cortex Stimulation Pain Control</brief_title>
	<detailed_description>This prospective , blind randomize crossover study compare two stimulation paradigm three different group patient receive motor cortex stimulation . The aim study examine effectiveness modality control blind manner , do previous study . There two primary purpose study . The first compare two different stimulation paradigm : `` high '' level stimulation ( i.e . stimulator activate 'on ' 10 minute , 'off ' 2 hour ; presume therapeutic dose ) ; versus `` low '' stimulation ( 'on ' 1 minute , 'off ' 6 hour ; presume subtherapeutic dose ) , prospective blind crossover study design . The second purpose study , examine outcome MCS three different pain group . These : 1 . Unilateral upper extremity neuropathic pain brachial plexus avulsion , stump pain phantom limb pain 2 . Neuropathic deafferentation facial pain 3 . Upper extremity complex regional pain syndrome ( CRPS ) Measurements effect motor cortex stimulation include visual analogue scale ( VAS ) perceive pain , McGill Pain Questionnaire , SF-36 quality life questionnaire , Beck Depression Inventory-II , standard 7-point patient global impression change ( PGIC ) , medication log ( verified pharmacy record ) employment status questionnaire . Adverse event record visit . Table 1 : Visit Study Week Standard Care 0a 1b 12c 24d 1a 2e 3f 4g F/Uh Clinic Visit X X X X X X Consent X Surgery X X X Program MCS X X X X X X VAS X X X X X X X SF-36 X X X X X X X Medications Log X X X X Employment Status X X X X McGill Pain X X X X X X X Beck Depression II X X X X Global impression change X X 1 . Screening visit consideration MCS 2 . Immediate post-op visit , randomization high low setting 3 . 12 week crossover point 4 . Final study visit , MCS program 'best ' setting 5 . Trial period MCS , last 1 2 week 6 . Clinic visit determine efficacy MCS removal temporary external system . 7 . Permanent implantation MCS , trial successful 8 . Follow-up require .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Phantom Limb</mesh_term>
	<mesh_term>Complex Regional Pain Syndromes</mesh_term>
	<mesh_term>Reflex Sympathetic Dystrophy</mesh_term>
	<mesh_term>Facial Pain</mesh_term>
	<mesh_term>Causalgia</mesh_term>
	<criteria>1 . Diagnosis one follow three category : Unilateral upper extremity neuropathic pain phantom limb pain , stump pain brachial plexus avulsion Neuropathic deafferentation facial pain Upper extremity complex regional pain syndrome ( CRPS ) 2 . Pain refractory conservative method ( e.g . medication , regional block ) review chronic pain clinical physician 3 . Patient consider good candidate neurosurgery , i.e . medical problem would preclude surgery 4 . Patients willing provide informed consent . 1 . Patients consider medically fit neurosurgery . 2 . Patients exhaust conservative method pain control , prior consider motor cortex stimulation . 3 . Patients able provide inform consent . 4 . Patients unable magnetic resonance imaging ( MRI ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Motor cortex stimulation</keyword>
	<keyword>neuropathic</keyword>
	<keyword>pain</keyword>
	<keyword>complex regional pain syndrome</keyword>
	<keyword>deafferentation facial pain</keyword>
</DOC>